Seer, Inc. (NASDAQ:SEER) Short Interest Down 34.8% in June

Seer, Inc. (NASDAQ:SEER) was the target of a large decrease in short interest in the month of June. As of June 15th, there was short interest totaling 191,696 shares, a decrease of 34.8% from the May 31st total of 293,816 shares. Based on an average daily trading volume, of 127,131 shares, the short-interest ratio is currently 1.5 days. Approximately 0.4% of the company’s shares are short sold.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on the company. TD Cowen upgraded Seer to a “strong-buy” rating in a report on Monday, April 13th. Canaccord Genuity Group began coverage on shares of Seer in a report on Monday, May 4th. They issued a “buy” rating and a $4.00 price objective on the stock. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Seer in a research report on Tuesday, April 21st. Two equities research analysts have rated the stock with a Strong Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of $4.00.

Hedge Funds Weigh In On Seer

Several institutional investors have recently modified their holdings of SEER. Occudo Quantitative Strategies LP purchased a new stake in shares of Seer during the second quarter worth $25,000. Marshall Wace LLP acquired a new position in Seer during the 4th quarter worth $85,000. Quadrature Capital Ltd purchased a new stake in Seer during the 4th quarter worth about $101,000. Barclays PLC raised its position in Seer by 685.0% in the 4th quarter. Barclays PLC now owns 60,717 shares of the company’s stock valued at $111,000 after purchasing an additional 52,982 shares in the last quarter. Finally, Corient Private Wealth LLC purchased a new position in shares of Seer in the 4th quarter valued at about $116,000. Institutional investors and hedge funds own 75.20% of the company’s stock.

Seer Price Performance

NASDAQ SEER opened at $1.63 on Thursday. The company has a market cap of $89.62 million, a P/E ratio of -1.31 and a beta of 1.59. The stock has a 50-day moving average of $1.80 and a two-hundred day moving average of $1.83. Seer has a 1-year low of $1.62 and a 1-year high of $2.41.

Seer (NASDAQ:SEER) last posted its quarterly earnings data on Wednesday, May 13th. The company reported ($0.30) EPS for the quarter, meeting the consensus estimate of ($0.30). Seer had a negative net margin of 464.78% and a negative return on equity of 26.58%. The business had revenue of $2.79 million during the quarter, compared to analyst estimates of $3.60 million.

Seer Company Profile

Seer, Inc is a life sciences company focused on pioneering next-generation proteomics, the large-scale study of proteins and their functions in complex biological systems. By leveraging proprietary nanoparticle-based technology, Seer’s platform enables high-throughput, unbiased protein analysis from biological samples, addressing a critical bottleneck in drug discovery, biomarker research and precision medicine.

The company’s flagship Proteograph Product Suite combines engineered nanoparticle assays with advanced mass spectrometry and bioinformatics pipelines to deliver deep proteomic coverage in a scalable workflow.